Moreover, inhibition of AKT-signaling attenuated co-localization between Rad51 and γ-H2AX foci after Dox treatment (Figure 7C, bottom panel), thus suggesting a failure in the recruitment of Rad51 to DSBs in AKT-inhibited tumor cells after Dox treatment. The gene discussed is AKT1; the disease is neoplasm.